Register today for this one day hybrid workshop on March 8, 2024. The workshop will focus on myelodysplastic syndromes, myeloproliferative neoplasms, and acute myeloid leukemia. Internationally recognized clinical and laboratory experts will highlight the cutting-edge science and recent evidence-based advances in clinical care of myeloid malignancies.
The target audience for this CME accredited event includes clinical and laboratory-based physicians, trainees, laboratory investigators, pharmacists, nurses, nurse practitioners, and physician assistants.